Didn't need to bring it up Bundaone. Unusually Marc commented on the current SP situation straight up.
He postulated it could be due to recent poor performances in the biotech sector ,eg BIT and MSB on asx and AMDR on nasdaq, that has led to a wariness in our sector. That may not satisfy you but it's all I got.